Annual report pursuant to Section 13 and 15(d)

Net Loss per Common Share (Schedule of Diluted Weighted Average Shares Outstanding) (Details)

v3.22.1
Net Loss per Common Share (Schedule of Diluted Weighted Average Shares Outstanding) (Details) - shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 21,904,246 19,216,795
Warrants to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 4,528,196 3,419,812
Options to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 832,134 1,103,643
Unvested Restricted Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 16,363,068 14,302,004
Unvested Restricted Stock Units [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 180,848 391,336